Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Publications
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Katrien Swerts
Profile
Projects
Publications
Activities
Awards & Distinctions
26
Results
2012
Isolation of disseminated neuroblastoma cells from bone marrow aspirates for pretreatment risk assessment by array comparative genomic hybridization
Mado Vandewoestyne
Candy Kumps
Katrien Swerts
Björn Menten
Tim Lammens
Jan Philippé
Katleen De Preter
Genevieve Laureys
Nadine Van Roy
Franki Speleman
et al.
A1
Journal Article
in
INTERNATIONAL JOURNAL OF CANCER
2012
N-Cadherin in neuroblastoma disease : expression and clinical significance
Tim Lammens
Katrien Swerts
Lara Derycke
ANNEMIE DE CRAEMER
Sara De Brouwer
Katleen De Preter
Nadine Van Roy
Jo Vandesompele
Franki Speleman
Jan Philippé
et al.
A1
Journal Article
in
PLOS ONE
2012
2009
Array comparative genomic hybridization and flow cytometry analysis of spontaneous abortions and mors in utero samples
Björn Menten
Katrien Swerts
Barbara Delle Chiaeie
Sandra Janssens
Karen Buysse
Jan Philippé
Franki Speleman
A1
Journal Article
in
BMC MEDICAL GENETICS
2009
Hop bitter acids efficiently block inflammation independent of GRα, PPARα, or PPARγ
Marjan Van Cleemput
Arne Heyerick
Claude Libert
Katrien Swerts
Jan Philippé
Denis De Keukeleire
Guy Haegeman
Karolien De Bosscher
A1
Journal Article
in
MOLECULAR NUTRITION & FOOD RESEARCH
2009
Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study
Joëlle Vermeulen
Katleen De Preter
Arlene Naranjo
Liesbeth Vercruysse
Nadine Van Roy
Jan Hellemans
Katrien Swerts
Sophie Bravo
Paolo Scaruffi
Gian Paolo Tonini
et al.
A1
Journal Article
in
LANCET ONCOLOGY
2009
2008
Minimal disease monitoring by QRT-PCR: guidelines for identification and systematic validation of molecular markers prior to evaluation in prospective clinical trials
VF VIPREY
MA LASTOWSKA
MV CORRIAS
Katrien Swerts
MS JACKSON
SA BURCHILL
A1
Journal Article
in
JOURNAL OF PATHOLOGY
2008
Minimal residual disease detection at day 35 in childhood acute lymphoblastic leukemia: Which technique(s) to use?
Katrien Swerts
Barbara De Moerloose
B DENYS
M BAKKUS
Bruno Verhasselt
Yves Benoit
Jan Philippé
C3
Conference
2008
Which technique(s) to use when studying minimal residual disease at day 35 in childhood acute lymphoblastic leukemia: a multicenter approach.
Barbara De Moerloose
Katrien Swerts
M BAKKUS
A UYTTEBROECK
N BOECKX
P VANDENBERGHE
Bruno Verhasselt
A VAN DAMME
C DEMANET
Jan Philippé
et al.
C3
Conference
2008
Which technique(s) to use when studying minimal residual disease at day 35 in childhood acute lymphoblastic leukemia: a multicenter approach.
Barbara De Moerloose
Katrien Swerts
M Bakkus
A Uyttebroeck
N Boeckx
P Vandenberghe
Bruno Verhasselt
A Van Damme
C Demanet
Yves Benoit
et al.
C3
Conference
2008
2007
DRAQ5: improved flow cytometric residual disease detection DNA content analysis and minimal in childhood malignancies
Katrien Swerts
Nadine Van Roy
Yves Benoit
Genevieve Laureys
Jan Philippé
A1
Journal Article
in
CLINICA CHIMICA ACTA
2007
Prognostic value of BCL2L13 expression in childhood B-cell acute lymphoblastic leukaemia
Katrien Swerts
Barbara De Moerloose
Catharina Dhooge
Yves Benoit
Jan Philippé
C3
Conference
2007
Standardisation of operating procedures for the detection of minimal disease by QRT-PCR in children with neuroblastoma: Quality assurance on behalf of SIOPEN-R-NET
VF VIPREY
MV CORRIAS
B KAGEDAL
S OLTRA
Katrien Swerts
A VICHA
R LADENSTEIN
SA BURCHILL
A1
Journal Article
in
EUROPEAN JOURNAL OF CANCER
2007
2006
Opsporing en klinisch belang van minimale residuele ziekte bij neuroblastoompatiënten
Katrien Swerts
Yves Benoit
Genevieve Laureys
Jan Philippé
A2
Journal Article
in
TIJDSCHRIFT VOOR GENEESKUNDE
2006
Potential application of ELAVL4 real-time quantitative reverse transcription-PCR for detection of disseminated neuroblastoma cells
Katrien Swerts
Barbara De Moerloose
Catharina Dhooge
Jo Vandesompele
C HOYOUX
K BEISKE
Yves Benoit
Genevieve Laureys
Jan Philippé
A1
Journal Article
in
CLINICAL CHEMISTRY
2006
Prognostic significance of multidrug resistance-related proteins in childhood acute lymphoblastic leukaemia
Katrien Swerts
Barbara De Moerloose
Catharina Dhooge
Genevieve Laureys
Yves Benoit
Jan Philippé
A1
Journal Article
in
EUROPEAN JOURNAL OF CANCER
2006
2005
Detectie van minimale residuele ziekte bij kinderen met neuroblastoom
Barbara De Moerloose
Katrien Swerts
A4
Journal Article
in
VERHANDELINGEN VAN DE KONINKLIJKE ACADEMIE VOOR GENEESKUNDE VAN BELGIË
2005
Detecting minimal residual disease in neuroblastoma patients - the present state of the art
K BEISKE
PF AMBROS
SA BURCHILL
IY CHEUNG
Katrien Swerts
A1
Journal Article
in
CANCER LETTERS
2005
Multidrug resistance and minimal residual disease in childhood malignancies
Katrien Swerts
J Philippe
G Laureys
Dissertation
2005
Standardization of the immunocytochemical detection of neuroblastoma cells in bone marrow
Katrien Swerts
PF AMBROS
C BROUZES
JMF NAVARRO
N GROSS
D RAMPLING
R SCHUMACHER-KUCKELKORN
AR SEMENTA
R LADENSTEIN
K BEISKE
A1
Journal Article
in
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
2005
2004
Comparison of two functional flow cytometric assays to assess P-gp activity in acute leukemia
Katrien Swerts
Barbara De Moerloose
Catharina Dhooge
Lucien Noens
Genevieve Laureys
Yves Benoit
Jan Philippé
A1
Journal Article
in
LEUKEMIA & LYMPHOMA
2004
Four-color flow cytometric detection of residual neuroblastoma cells
Jan Philippé
Katrien Swerts
Barbara De Moerloose
Catharina Dhooge
Yves Benoit
Genevieve Laureys
C1
Conference
2004
2003
Actuele inzichten en prognostische karakteristieken van het neuroblastoom
Barbara De Moerloose
Katrien Swerts
Genevieve Laureys
A2
Journal Article
in
TIJDSCHRIFT VOOR GENEESKUNDE
2003
The combined analysis of P-glycoprotein expression and activity predicts outcome in childhood acute lymphoblastic leukemia
Barbara De Moerloose
Katrien Swerts
Yves Benoit
Genevieve Laureys
Tom Loeys
Jan Philippé
Catharina Dhooge
A1
Journal Article
in
PEDIATRIC HEMATOLOGY AND ONCOLOGY
2003
The quantification of MDR1 transcripts by real-time RT-PCR does not predict drug resistance in childhood acute lymphoblastic leukemia
Katrien Swerts
Barbara De Moerloose
B LEUS
Catharina Dhooge
Genevieve Laureys
Bruno Verhasselt
Yves Benoit
Jan Philippé
C1
Conference
2003
2001
Combined evaluation of P-glycoprotein expression and activity contributes to the identification of children at risk for leukaemic relapse
Barbara De Moerloose
Katrien Swerts
Catharina Dhooge
S STEYAERT
Yves Benoit
Genevieve Laureys
Jan Philippé
C1
Conference
2001
Imaging with Technetium-99m sestamibi does not predict drug resistance or outcome in childhood neuroblastoma
C VAN DE WIELE
B DE MOERLOOSE
Genevieve Laureys
Catharina Dhooge
Katrien Swerts
Yves Benoit
J PHILIPP
Rudi Dierckx
C3
Conference
2001